Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation

Blood Cancer Journal

Volumn 1, Issue 11, 2011, Pages

  Tamai, H ^a   Miyake, K ^a   Yamaguchi, H ^a   Takatori, M ^a   Dan, K ^a   Inokuchi, K ^a   Shimada, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

GVL effect; Mixed lineage leukemia; MLL AFF1; S100A6; TNF

Indexed keywords

CALCYCLIN; CASPASE 3; CASPASE 8; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INHIBITION; GRAFT VERSUS LEUKEMIA EFFECT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

EID: 84855592875     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.37     Document Type: Article

References (34)

1. Harper DP, Aplan PD. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res 2008; 68: 10024-10027.
2. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909-1915. (Pubitemid 34615770)
3. Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M. The allogeneic graft-versus-cancer effect. Br J Haematol 2009; 147: 614-633.
4. Sastry M, Ketchem RR, Crescenzi O, Weber C, Lubienski MJ, Hidaka H. The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins. Structure 1998; 6: 223-231. (Pubitemid 28153885)
5. Tsoporis JN, Izhar S, Parker TG. Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J Biol Chem 2008; 283: 30174-30183.
6. Leoeniak W, Somnicki ŁP, Filipek A. S100A6 - new facts and features. Biochem Biophys Res Commun 2009; 390: 1087-1092.
7. Yamaguchi H, Hanawa H, Uchida N, Inamai M, Sawaguchi K, Mitamura Y et al. Multistep pathogenesis of leukemia via the MLLAF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Exp Hematol 2009; 37: 701-714.
8. Balasubramanian N, Advani SH, Zingde SM. Protein kinase C isoforms in normal and chronic myeloid leukemic neutrophils. Distinct signal for PKC alpha by immunodetection on PVDF membrane, decreased expression of PKC alpha and increased expression of PKC delta in leukemic neutrophils. Leuk Res 1998; 22: 597-604. (Pubitemid 28327462)
9. Thomas M, Gessner A, Vornlocher HP, Hadwiger P, Greil J, Heidenreich O. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 2005; 106: 3559-3566. (Pubitemid 41609194)
10. Tamai H, Miyake K, Takatori M, Miyake N, Yamaguchi H, Dan K et al. Activated K-Ras protein accelerates human MLL/AF4- induced leukemo- lymphomogenicity in a transgenic mouse model. Leukemia 2011; 25: 888-891.
11. Wiederschain D, Kawai H, Shilatifard A, Yuan ZM. Multiple mixed lineage leukemia (MLL) fusion proteins suppress p53-mediated response to DNA damage. J Biol Chem 2005; 280: 24315-24321. (Pubitemid 40934513)
12. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S et al. Fas and perforin pathways as major mechanisms of T cellmediated cytotoxicity. Science 1994; 265: 528-530. (Pubitemid 24264998)
13. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370: 650-652. (Pubitemid 24270685)
14. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193: 661-670. (Pubitemid 32524460)
15. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 2001; 7: 94-100. (Pubitemid 32095647)
16. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 2002; 168: 1356-1361. (Pubitemid 34094506)
17. Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H et al. Critical role for tumor necrosis factor-related apoptosis inducing ligand in immune surveillance against tumor development. J Exp Med 2002; 195: 161-169. (Pubitemid 34461260)
18. Schmaltz C, Alpdogan O, Kappel BJ, Muriglan SJ, Rotolo JA, Ongchin J et al. T cells require TRAIL for optimal graft-versustumor activity. Nat Med 2002; 8: 1433-1437. (Pubitemid 36019429)
19. Inukai T, Zhang X, Goto M, Hirose K, Uno K, Akahane K et al. Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity. Leukemia 2006; 20: 2119-2129. (Pubitemid 44782837)
20. Baudier J, Delphin C, Grunwald D, Khochbin S, Lawrence JJ. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci USA 1992; 89: 11627-11631.
21. Fernandez-Fernandez MR, Rutherford TJ, Fersht AR. Members of the S100 family bind p53 in two distinct ways. Protein Sci 2008; 17: 1663-1670.
22. Mueller A, Schäfer BW, Ferrari S, Weibel M, Makek M, Höchli M et al. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 2005; 280: 29186-29193. (Pubitemid 41161370)
23. Slomnicki LP, Nawrot B, Leoeniak W. S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol 2008; 41: 784-790.
24. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C et al. Tumor suppressor p53 protein is a new target for the metastasis- associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001; 276: 22699-22708.
25. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA 2005; 102: 4735-4740. (Pubitemid 40471523)
26. Lin J, Blake M, Tang C, Zimmer D, Rustandi RR, Weber DJ et al. Inhibition of p53 transcriptional activity by the S100B calciumbinding protein. J Biol Chem 2001; 276: 35037-35041.
27. Scotto C, Delphin C, Deloulme JC, Baudier J. Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C. Mol Cell Biol 1999; 19: 7168-7180. (Pubitemid 29441897)
28. van Dieck J, Fernandez-Fernandez MR, Veprintsev DB, Fersht AR. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem 2009; 284: 13804-13811.
29. Joo JH, Yoon SY, Kim JH, Paik SG, Min SR, Lim JS et al. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J Cell Biochem 2008; 103: 1183-1197.
30. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
31. Moorman AV, Harrison CJ, Buck GA, Richards SM, Secker-Walker LM, Martineau M et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007; 109: 3189-3197. (Pubitemid 46572503)
32. Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemias. Leukemia 1995; 9: 762-769.
33. Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG et al. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 1996; 10: 952-956. (Pubitemid 26235926)
34. Eden TO, Pieters R, Richards S. Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG). Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5659 children. Br J Haematol 2010; 149: 722-733.